|Bid||53.68 x 100|
|Ask||58.62 x 400|
|Day's Range||57.10 - 57.86|
|52 Week Range||43.90 - 59.11|
|PE Ratio (TTM)||24.14|
|Dividend & Yield||1.56 (2.69%)|
|1y Target Est||N/A|
Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs. Since 2011, Mylan has bought 99 percent stakes in five companies across the U.S. that own plants which process coal to reduce smog-causing emissions. Mylan is one of only a few public companies, and the only publicly-traded pharmaceutical maker, that uses these tax credits, a Reuters review of a comprehensive database of filings with the U.S. Securities and Exchange Commission found.
Arthur J. Gallagher & Co. (AJG) has announced to take over Armstrong/Robitaille/Riegle, Inc., and Ann Arbor Business Advisors, LLC. in Michigan and Total Reward Group in England.
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Arthur J. Gallagher & Co. with the following peers – Marsh & McLennan Companies, Inc., Brown & Brown, Inc., Aon plc and Willis Towers Watson Public Limited Company (MMC-US, BRO-US, AON-US and WLTW-US). Arthur J. Gallagher & Co.’s dividend yield is 3.38 percent and its ... Read more (Read more...)